Seres Therapeutics
MCRB
MCRB
123 hedge funds and large institutions have $588M invested in Seres Therapeutics in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 35 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
123
Holders Change
+4
Holders Change %
+3.36%
% of All Funds
1.98%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
41
Reduced
35
Closed
16
Calls
$1.87M
Puts
$1.24M
Net Calls
+$627K
Net Calls Change
-$378K
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$25.6M |
| 2 |
2
Jennison Associates
New York
|
$3.74M |
| 3 |
EP
3
Eversept Partners
New York
|
$12.3M |
| 4 |
4
Hudson Bay Capital Management
Stamford,
Connecticut
|
$3.25M |
| 5 |
5
Millennium Management
New York
|
$1.15M |
